Patent SG-11201407619S-A (SG)
Title: Schmallenberg virus (sbv) vaccine, methods of production, and uses thereof
Inventor: NIKOLIN VELJKO
IPC: A61K39/00
Filed: 2013-05-29
Abstract: (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 5 December 2013 (05.12.2013) WIPOIPCT (10) International Publication Number WO 2013/181270 A1 (51) International Patent Classification: C07K14/175 (2006.01) A61K39/12 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: PCT/US2013/043146 29 May 2013 (29.05.2013) English English (30) Priority Data: 12170631.1 13157875.9 1 June 2012 (01.06.2012) EP 5 March 2013 (05.03.2013) EP (71) Applicant (for all designated States except US): BOEHRINGER INGELHEIM VETMEDICA GMBH [DE/DE]; Binger Strasse 173, 55216 Ingelheim am Rhein (DE). (72) Inventors; and (71) Applicants (for US only): NIKOLIN, Veljko [RS/DE]; Boehringer Ingelheim GmbH, Corporate Patents, Binger Strasse 173, 55216 Ingelheim am Rhein (DE). STADLER, Konrad [AT/DE]; Boehringer Ingelheim GmbH, Corpor­ ate Patents, Binger Strasse 173, 55216 Ingelheim am Rhein (DE). LISCHEWSKI, Axel [DE/DE]; Boehringer Ingle- him GmbH, Corporate Patents, Binger Strasse 173, 55216 Ingelheim am Rhein (DE). BRIX, Alexander [DE/US]; c/o VP, IP, Legal, Boehringer Ingelheim USA Corp., 900 Ridgebury Road, P.O. Box 368, Ridgefield, CT 06877- 0368 (US). KNITTEL, Jeffrey P. [US/US]; c/o VP, IP, Legal, Boehringer Ingelheim USA Corp., 900 Ridgebury Rd., P.O. Box 368, Ridgefield, Connecticut 06877-0368 (US). TOEPFER, Katharina Hedwig [DE/DE]; Boehringer Ingelheim GmbH, Corporate Patents, Binger Strasse 173, 55216 Ingelheim am Rhein (DE). (74) Agents: MORRIS, Michael P. et al.; Boehringer Ingel­ heim Pharmaceuticals, Inc., 900 Ridgebury Road, P.O. Box 368, Ridgefield, CT 06877-0368 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) — with sequence listing part of description (Rule 5.2(a)) © l> CJ i-H 00 i-H o CJ (54) Title: SCHMALLENBERG VIRUS (SBV) VACCINE, METHODS OF PRODUCTION, AND USES THEREOF (57) Abstract: The present invention relates to the field of vaccines and medicaments for the prophylaxis and treatment of infectious diseases in ruminants. In particular, relates it to inactivated Schmallenberg virus (SBV) useful as vaccine or medicament for prevent­ ing or treating viremia, the transmission and clinical symptoms, in particular malformations in newborn ruminants such as cattle, sheep and goats, induced by SBV.